Since 2019, Estelle has joined the TFS HealthScience team, bringing with her 21 years of clinical trials experience, from Phase I to Phase III, in an international environment. For 17 years, she specialized in Phase I trials for solid tumors. For the past 7 years, she is dedicated to early phases trials, with a strong understanding of all aspects and the challenges and flexibility required with cohort managements, developing a close collaboration with the early phases Investigators in many countries. She brings passion to her oncology team, with a strong focus on delivering successful studies.
Learn more about our mission and values, and meet our executive leadership team.
Thought Leadership Written by Estelle Guiheneuf

Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know
Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know

Revolutionizing Oncology Trials: The Power of Immunotherapy and Precision Medicine in Cancer Research